BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Akili and Shionogi Announce Strategic Partnership to Develop and Commercialize Digital Therapeutics in Key Asian Markets

  Akili to Create First-of-its-kind International Digital Medicine Development and Commercial Platform

  March 7, 2019

   · 

  7 min read
• Drug Development

  BioArctic: Eisai Announces Timelines for the Single Confirmatory Phase 3 Study With BAN2401 in Warly Alzheimer’s Disease

  BioArctic AB informs that Eisai today announced the timelines for the single confirmatory Phase 3 study with BAN2401 in early Alzheimer´s disease patients i.e. mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease.

  March 7, 2019

   · 

  6 min read
• Business

  Qure.ai Taps Former GE Healthcare Exec as Chief Commercial Officer

  Chiranjiv Singh will lead Qure.ai’s global market expansion and adoption

  March 7, 2019

   · 

  2 min read
• Drug Development

  Alligator Bioscience: First Patient Dosed in Phase I study of ATOR-1015

  Dose-escalation study commences with first-in-class bispecific CTLA-4 antibody

  March 7, 2019

   · 

  3 min read
• Business

  LumiThera Announces an Agreement with Andrec Corporation S.A. to Distribute the Valeda Light Delivery System in Colombia and Several Latin American Countries

  LumiThera Inc. announced an agreement with Andrec Corporation S.A. to exclusively distribute the Valeda™ Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in Colombia and several Latin America countries.

  March 7, 2019

   · 

  3 min read
• BioForest

  Lupus Foundation of America Launches Global Research News Hub

  Across the globe, scores of lupus research studies are underway – more than any other time in history.

  March 7, 2019

   · 

  2 min read
• Drug Development

  The Journal of Addiction Medicine Publishes Patient-centered Outcomes from the Phase 3 Study of SUBLOCADE™ (Buprenorphine Extended-Release) Injection in Patients with Moderate to Severe Opioid Use Disorder (OUD)

  Six monthly injections of SUBLOCADE™ improved patient health status and health-related quality of life compared to placebo in 24-week pivotal trial

  March 7, 2019

   · 

  14 min read